Boston Partners
AKBA icon

Boston Partners’s Akebia Therapeutics AKBA Stock Holding History

Boston Partners’s Portfolio AKBA Stock Details AKBA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-70,003
Closed -$531K – 656
2020
Q1 		$531K Sell
70,003
-169,815
-71% -$1.32M ﹤0.01% 592
2019
Q4 		$1.52M Sell
239,818
-61,785
-20% -$294K ﹤0.01% 538
2019
Q3 		$1.18M Buy
301,603
+55,337
+22% +$237K ﹤0.01% 571
2019
Q2 		$1.19M Sell
246,266
-36,778
-13% -$209K ﹤0.01% 602
2019
Q1 		$2.32M Buy
283,044
+3,666
+1% +$25.2K ﹤0.01% 523
2018
Q4 		$1.54M Buy
+279,378
New +$2.19M ﹤0.01% 588

Other funds holding AKBA

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $408M AUM 318.81% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return